1 publication

• Published Subscription 10 Nov 2023

  Tirzepatide : Treatment For Diabetes Mellitus II & Obesity

  By Nehal Gandhi, Dr. Vikram pandya, Harsh Gandhi, Pintulal Sen, Dhananjay Gamit

  Abstract: Tirzepatide is a novel medication that the FDA has approved to treat type 2 diabetes mellitus. Tirzepatide is used off-label to treat obesity because` of its powerful weight-loss effects. It Known as the "twin epidemics," the prevalence of obesity and diabetes is a growing issue worldwide, particularly in wealthy nations. Therefore, cutting-edge therapeutic strategies are required. Tirzepatide, Known as a "twincretin," tirzepatide is the only dual glucagon-like peptide-1 (GLP-1) and …

  Published in Research & Reviews: A Journal of Drug Formulation, Development and Production · Vol. 10, Issue 2, 2023 · pp. 23–32 Read article →